Asma Guardian App for Childhood Asthma
Trial Summary
What is the purpose of this trial?
This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems likely that children can continue their current asthma treatments while participating.
What data supports the effectiveness of the treatment Asma Guardian App for Childhood Asthma?
Is the Asma Guardian App safe for use in children with asthma?
What makes the Asma Guardian treatment unique for childhood asthma?
The Asma Guardian app is unique because it is designed specifically for children aged 0-12 years and their caregivers, focusing on interactions between them to support asthma self-management. Unlike other treatments, it provides tailored feedback and uses engaging features like animated graphics to help children understand and manage their asthma effectively.26101112
Research Team
Elizabeth Matsui, MD
Principal Investigator
University of Texas at Austin
Eligibility Criteria
This trial is for Hispanic/Latinx parents with a child aged 5-12 who has asthma, uses long-term control medication, or meets criteria for persistent disease. The child must have had nocturnal symptoms and an exacerbation in the past year. Families need tech access for the app-based study but can't join if involved in another asthma study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive immediate access to the Asma Guardian app for asthma management, education, and environmental intervention for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of asthma symptoms and app engagement
Delayed Access
Participants initially without access receive 1 month of access to the Asma Guardian app after the 6-month study visit
Treatment Details
Interventions
- Asma Guardian
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator